Frontlight ResearchEarly access
Taking people in FrancePhase 4
Lidocaine through a vein plus ropivacaine at incision sites after colorectal cancer surgery
Tests lidocaine with ropivacaine for recovery after keyhole colorectal cancer surgery in adults.
Key facts
- Who runs it
- Centre Hospitalier Universitaire Amiens Picardie
- Where
- Amiens Cedex 1, FranceSee the site
- Trial code
- Registry title
- Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic surgery: a randomized controlled trial
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 182 people, planned
- Started
- 24 Apr 2026
- Expected to end
- 1 Jul 2028
- Type of study
- Interventional
- Record updated
- 22 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having planned keyhole (laparoscopic) surgery for colorectal cancer. It tests IV lidocaine plus ropivacaine at the cut sites for recovery.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Colorectal cancer, scheduled for laparoscopic surgery.
- Earlier treatment
- People who used opioids or opioid-like drugs before surgery cannot join.
Main reasons for not taking part
- Allergy or contraindication to lidocaine, ropivacaine or the other listed drugs
- Surgery by open cut (laparotomy), or surgery not for cancer
- Chronic pain lasting more than 3 months
- Psychiatric disorders
- Pregnant or breastfeeding women
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Patients undergoing scheduled laparoscopic colorectal cancer surgery
- Patients aged 18 years or older
- Highly effective method of contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intravaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, intrauterine hormone-releasing system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence
- Informed consent and signed agreement
- Enrollment in a Social Security plan
Who cannot take part
- Colorectal surgery by laparotomy
- Allergy or contraindication to lidocaine or ropivacaine,
- Allergy or contraindication to paracetamol, nefopam, ketamine, propofol, dexamethasone, sufentanil , Celebrex or Parecoxib, , morphine derivatives, and Colorectal surgery by laparotomy
- Colorectal surgery not indicated for cancer treatment
- Patients suffering from psychiatric disorders
- Patients under guardianship, conservatorship, or legal protection
- Chronic preoperative pain (defined as pain persisting for more than 3 months),
- Preoperative use of opioids or opioid derivatives,
- Patients for whom pain self-assessment using a self-assessment scale cannot be performed (non-communicative, non-English-speaking, etc.)
- Pregnant or breastfeeding women
This trial is currently available in France.
- Centre Hospitalier Universitaire Amiens PicardieAmiens Cedex 1, FranceTaking people
About the trial
What the trial wants to find out
Evaluate the effectiveness of combining intravenous lidocaine and ropivacaine infiltration of laparoscopic trocar sites on postoperative recovery as assessed using the QOR-15 twenty-four hours after colorectal surgery.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic surgery: a randomized controlled trial
- Plain-language title
- Lidocaine through a vein plus ropivacaine at incision sites after colorectal cancer surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 22 September 2026